Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1984 1
1987 2
1988 1
1989 2
1990 1
1991 2
1992 2
1993 2
1994 2
1995 6
1996 5
1997 3
1998 5
1999 5
2000 5
2001 6
2002 3
2003 6
2004 4
2005 1
2006 5
2007 3
2008 2
2009 1
2013 1
2014 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

75 results

Results by year

Filters applied: . Clear all
Page 1
Diseases with DNA damage-processing defects.
Timme TL, Moses RE. Timme TL, et al. Am J Med Sci. 1988 Jan;295(1):40-8. doi: 10.1097/00000441-198801000-00009. Am J Med Sci. 1988. PMID: 3276189 Review.
Gene therapy for prostate cancer.
Gdor Y, Timme TL, Miles BJ, Kadmon D, Thompson TC. Gdor Y, et al. Among authors: timme tl. Expert Rev Anticancer Ther. 2002 Jun;2(3):309-21. doi: 10.1586/14737140.2.3.309. Expert Rev Anticancer Ther. 2002. PMID: 12113054 Review.
Therapeutic targets for metastatic prostate cancer.
Timme TL, Satoh T, Tahir SA, Wang H, Teh BS, Butler EB, Miles BJ, Amato RJ, Kadmon D, Thompson TC. Timme TL, et al. Curr Drug Targets. 2003 Apr;4(3):251-61. doi: 10.2174/1389450033491127. Curr Drug Targets. 2003. PMID: 12643475 Review.
In situ gene therapy for prostate cancer: immunomodulatory approaches.
Thompson TC, Timme TL, Ebara S, Satoh T, Yang G, Wang J, Miles BJ, Ayala G, Wheeler TM, Kadmon D. Thompson TC, et al. Among authors: timme tl. Expert Opin Biol Ther. 2001 May;1(3):481-95. doi: 10.1517/14712598.1.3.481. Expert Opin Biol Ther. 2001. PMID: 11727520 Review.
Transgenic models for the study of prostate cancer.
Thompson TC, Truong LD, Timme TL, Kadmon D, McCune BK, Flanders KC, Scardino PT, Park SH. Thompson TC, et al. Among authors: timme tl. Cancer. 1993 Feb 1;71(3 Suppl):1165-71. doi: 10.1002/1097-0142(19930201)71:3+<1165::aid-cncr2820711440>3.0.co;2-u. Cancer. 1993. PMID: 8428340 Review.
Transforming growth factor beta 1 as a biomarker for prostate cancer.
Thompson TC, Truong LD, Timme TL, Kadmon D, McCune BK, Flanders KC, Scardino PT, Park SH. Thompson TC, et al. Among authors: timme tl. J Cell Biochem Suppl. 1992;16H:54-61. doi: 10.1002/jcb.240501212. J Cell Biochem Suppl. 1992. PMID: 1289674 Review.
Expanding the therapeutic index of radiation therapy by combining in situ gene therapy in the treatment of prostate cancer.
Tetzlaff MT, Teh BS, Timme TL, Fujita T, Satoh T, Tabata K, Mai WY, Vlachaki MT, Amato RJ, Kadmon D, Miles BJ, Ayala G, Wheeler TM, Aguilar-Cordova E, Thompson TC, Butler EB. Tetzlaff MT, et al. Among authors: timme tl. Technol Cancer Res Treat. 2006 Feb;5(1):23-36. doi: 10.1177/153303460600500104. Technol Cancer Res Treat. 2006. PMID: 16417399 Free article. Review.
75 results